2021
DOI: 10.1002/nbm.4518
|View full text |Cite
|
Sign up to set email alerts
|

Ferumoxytol‐enhanced magnetic resonance T1 reactivity for depiction of myocardial hypoperfusion

Abstract: Myocardial T1 reactivity, defined as the relative change in T1 between rest and vasodilator-induced stress, has been proposed as a magnetic resonance imaging (MRI) biomarker of tissue perfusion. We hypothesize that the superparamagnetic iron-oxide nanoparticle, ferumoxytol, sensitizes T1 to changes in the intramyocardial vascular compartment and improves the sensitivity and specificity of T1 reactivity as an imaging biomarker of tissue perfusion. We aim to assess the diagnostic performance of ferumoxytol-enhan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 45 publications
0
6
0
Order By: Relevance
“…Stress T1 mapping can detect changes in MBV, but unfortunately it is not sensitive to MBF, RPP, or PvO 2 , 26,73 suggesting that T2 is more sensitive to the underlying hemodynamic effects. Stress T1 also suffers from a narrow dynamic range that has plagued attempts to identify ischemic or infarcted myocardium; even in healthy remote myocardium, the rest‐stress percent change measured using T1 is 6% or less, 26,29,77–79 as compared with a more than 10% change detected using T2 29,50 . Additionally, while some studies report being able to differentiate ischemic or infarcted tissue from healthy myocardium using stress T1, they only do so successfully when the regions are previously demarcated by perfusion or late gadolinium imaging 77,79 ; differentiation by stress T1 alone, when blinded to the location of the ischemia, fails 77 .…”
Section: Discussionmentioning
confidence: 99%
“…Stress T1 mapping can detect changes in MBV, but unfortunately it is not sensitive to MBF, RPP, or PvO 2 , 26,73 suggesting that T2 is more sensitive to the underlying hemodynamic effects. Stress T1 also suffers from a narrow dynamic range that has plagued attempts to identify ischemic or infarcted myocardium; even in healthy remote myocardium, the rest‐stress percent change measured using T1 is 6% or less, 26,29,77–79 as compared with a more than 10% change detected using T2 29,50 . Additionally, while some studies report being able to differentiate ischemic or infarcted tissue from healthy myocardium using stress T1, they only do so successfully when the regions are previously demarcated by perfusion or late gadolinium imaging 77,79 ; differentiation by stress T1 alone, when blinded to the location of the ischemia, fails 77 .…”
Section: Discussionmentioning
confidence: 99%
“…This approach also eliminates quantification errors resulting from double contrast injections. Several groups have since adopted the blood-pool imaging approach and applied it to myocardial stress testing ( 12 , 13 ). Instead of Ablavar ® , however, whose production was discontinued in 2017 due to low sales, these papers used Feraheme ® (ferumoxytol), an iron-based compound currently still approved in the U.S. as an iron supplement and used off-label as a blood-pool MRI contrast agent.…”
Section: Imaging Microvascular Dysfunctionmentioning
confidence: 99%
“…Research in the field remains strong; for instance, Ferumoxytol offers possibilities for both T 1 - and T 2 -weighting modalities, and so it continues to be under evaluation as a versatile vascular contrast agent. , Suspensions of fully dispersed citrate-stabilized MNPs ( d core 4 nm) have also been considered for T 1 -weighted angiography. , MNPs of many types have been developed for stem cell tracking following uptake. There are also many exciting recent examples of advanced multiresponsive magnetic iron oxide particles. For instance, smaller particles (in the 2–3 nm range, so the cores have no appreciable moment and are paramagnetic rather than superparamagnetic) are being developed for dual T 1 – T 2 contrast generation for evaluating vascular permeability in tumors .…”
Section: Introductionmentioning
confidence: 99%
“…Research in the field remains strong; for instance, Ferumoxytol offers possibilities for both T 1 - and T 2 -weighting modalities, and so it continues to be under evaluation as a versatile vascular contrast agent. 7 , 8 Suspensions of fully dispersed citrate-stabilized MNPs ( d core 4 nm) have also been considered for T 1 -weighted angiography. 9 , 10 MNPs of many types have been developed for stem cell tracking following uptake.…”
Section: Introductionmentioning
confidence: 99%